Suppr超能文献

[肝门部胆管癌。15例手术切除病例的研究]

[Klatskin tumor. A study of 15 resected cases].

作者信息

Santoro E, Sacchi M, Carboni F, Santoro R

机构信息

Service de chirurgie oncologique, institut Regina-Elena, Rome, Italie.

出版信息

Chirurgie. 1999 Apr;124(2):132-9; discussion 139-40. doi: 10.1016/s0001-4001(99)80055-5.

Abstract

STUDY AIM

Klatskin tumors are rare. Prognosis is still poor, and long term survival can be expected only after surgery, which is the treatment of choice. The aim of this study is to report the results of 15 resected cases and, by analysis of the literature, to emphasize the progress of the surgical treatment in hilar cholangiocarcinoma.

PATIENTS AND METHODS

Between 1990 and 1998, 27 patients affected by Klatskin tumor were observed. Eight women and seven men underwent surgical resection. The mean age was 59 years. Thirteen patients (48%) had curative resection (7 hilar resection (HR), 5 HR combined with partial hepatectomy (PH) and 1 HR + PH with portal vein resection). Two patients had palliative resection and surgical drainage.

RESULTS

One in-hospital death occurred right after hepatectomy with portal vein resection (6.6%). Postoperative morbidity was 40%. Patients were regularly followed. Ten patients died and 5 were alive at the time of this study. The 1, 2 and 3-year survival after a curative resection was 84%, 54% and 34%. The median survival was 28.5 months. Lymph node involvement did not show a statistically significant difference on median survival between the positive group and the negative group (26.2 vs 29.8 months) because of the small number of patients. Survival after hilar resection at 1, 2, 3, and 5 years was 100%, 57.1%, 28.6% and 0%. Four out of the 6 patients who underwent hilar resection combined with partial hepatectomy were still alive 1, 23, 29, 38 months after resection. Hepatectomy increased mortality (16% vs 0%). Palliative biliary resection and surgical drainage were successfully performed in 2 patients.

CONCLUSION

Aggressive surgical treatment of Klatskin tumor can improve the survival of patients. Careful pre-operative management has to be carried out by a multidisciplinary approach including surgeons, hepatologists, radiologists and pathologists. Hepatic resection including the caudate lobe is often performed in order to obtain microscopic tumor-free margins and curative resection (R0). Biliary drainage and treatment of cholangitis is mandatory before surgery in order to improve the surgical outcome. Surgical treatment is characterized by high technical difficulties, and better results can be achieved by hepatobiliary surgical teams.

摘要

研究目的

肝门部胆管癌较为罕见。其预后仍然较差,只有手术才有望实现长期生存,手术是首选治疗方法。本研究的目的是报告15例手术切除病例的结果,并通过文献分析强调肝门部胆管癌外科治疗的进展。

患者与方法

1990年至1998年间,观察了27例肝门部胆管癌患者。8名女性和7名男性接受了手术切除。平均年龄为59岁。13例患者(48%)接受了根治性切除(7例肝门部切除(HR),5例HR联合部分肝切除术(PH),1例HR + PH联合门静脉切除)。2例患者接受了姑息性切除及手术引流。

结果

1例患者在门静脉切除肝切除术后立即发生院内死亡(6.6%)。术后发病率为40%。对患者进行了定期随访。在本研究时,10例患者死亡,5例存活。根治性切除术后1年、2年和3年生存率分别为84%、54%和34%。中位生存期为28.5个月。由于患者数量较少,淋巴结受累在阳性组和阴性组之间的中位生存期上未显示出统计学显著差异(26.2对29.8个月)。肝门部切除术后1年、2年、3年和5年生存率分别为100%、57.1%、28.6%和0%。6例接受肝门部切除联合部分肝切除术的患者中,4例在切除术后1、23、29、38个月仍存活。肝切除术增加了死亡率(16%对0%)。2例患者成功进行了姑息性胆管切除及手术引流。

结论

积极的肝门部胆管癌外科治疗可提高患者生存率。必须通过包括外科医生、肝病学家、放射科医生和病理学家在内的多学科方法进行仔细的术前管理。为了获得显微镜下无肿瘤切缘及根治性切除(R0),常进行包括尾状叶在内的肝切除。术前必须进行胆管引流及胆管炎治疗,以改善手术效果。外科治疗技术难度高,肝胆外科团队可取得更好的效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验